Patents by Inventor Mohammad Arastoo

Mohammad Arastoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETECTING A TAU PROTEIN IN A SALIVA SAMPLE
    Publication number: 20250147051
    Abstract: The invention relates to an in vitro method for detecting a tau protein or fragment thereof in a saliva sample using a specific binding molecule, such as an antibody, directed to key epitopes of tau. The invention may find applications in diagnostics of tauopathies.
    Type: Application
    Filed: January 12, 2023
    Publication date: May 8, 2025
    Inventors: Richard LOFTHOUSE, Lewis Kirk PENNY, Mohammad ARASTOO, Soumya PALLIYIL SOMAN, Andrew Justin Radcliffe PORTER, Claude Michel WISCHIK
  • ANTI-TAU ANTIBODIES
    Publication number: 20230257452
    Abstract: The invention relates to specific binding molecules, such as antibodies, directed to key epitopes of tau. The specific binding molecules of the invention find applications in diagnostics and therapeutics of tauopathies including Alzheimer's disease.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 17, 2023
    Inventors: Charles Robert HARRINGTON, Soumya PALLIYIL SOMAN, Andrew Justin Radcliffe PORTER, Claude Michel WISCHIK, Mohammad ARASTOO, Lewis Kirk PENNY, Richard LOFTHOUSE
  • METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19
    Publication number: 20230165875
    Abstract: The present invention provides methods of treating COVID-19 in a subject using methylthioninium compounds.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 1, 2023
    Applicant: WisTa Laboratories Ltd.
    Inventors: Claude Michel Wischik, Mohammad Arastoo, Michael Philip Mazanetz
  • METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19
    Publication number: 20230165876
    Abstract: T he present invention provides methods of treating COV-ID-19 in a subject using methylthioninium compounds.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 1, 2023
    Applicant: WisTa Laboratories Ltd.
    Inventors: Claude Michel Wischik, Mohammad Arastoo, Michael Philip Mazanetz
  • METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF HYPOXEMIA
    Publication number: 20230158040
    Abstract: The present invention provides methods of alleviating hypoxemia in a subject through oral administration of a methylthioninium compound.
    Type: Application
    Filed: April 30, 2021
    Publication date: May 25, 2023
    Applicant: WisTa Laboratories Ltd.
    Inventors: Claude Michel Wischik, Mohammad Arastoo, Michael Philip Mazanetz